Sezary syndrome

From WikiMD.org
Jump to navigation Jump to search

Sezary syndrome (pronunciation: suh-ZAR-ee) is a rare form of cutaneous T-cell lymphoma characterized by the widespread redness and scaling of the skin (erythroderma) and the presence of malignant T cells (called Sezary cells) in the blood.

Etymology

The syndrome is named after the French dermatologist Albert Sézary, who first described the condition in 1938.

Symptoms

The most common symptoms of Sezary syndrome include:

Diagnosis

Diagnosis of Sezary syndrome is based on the presence of specific symptoms, a physical examination, and specialized tests. These tests may include a skin biopsy, blood tests to identify Sezary cells, and imaging tests to check for enlarged lymph nodes or organs.

Treatment

Treatment options for Sezary syndrome may include skin-directed therapy, systemic therapy, or a combination of both. Skin-directed therapies include topical corticosteroids, retinoids, and phototherapy. Systemic therapies include chemotherapy, biological therapy, and targeted therapy.

Prognosis

The prognosis for individuals with Sezary syndrome varies. Factors that can affect prognosis include the stage of the disease, the individual's overall health, and their response to treatment.

See also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski